Upcoming Webinar Presented by WorldCare Clinical to Discuss Functional Brain Imaging Using MRI: An Emerging Tool for Drug Development and Clinical Trials

Functional MRI paradigm to aid CNS drug development

BOSTON, Oct. 19, 2016 /PRNewswire-iReach/ -- WorldCare Clinical (WCC), a leading provider of imaging services to the pharmaceutical and biotechnology industry, today announced that it will host, in collaboration with Xtalks, a live presentation on Friday, October 28, 2016.  Dr. Maria Laura Blefari, Biomedical Engineer from WorldCare Clinical and Dr. Mykol Larvie, Physician, Department of Radiology, Director of Molecular Neuroimaging, Massachusetts General Hospital will discuss:

  • Scientific and clinical research insights on the principles of BOLD fMRI and its application as a clinical tool and drug development biomarker
  • Design of an fMRI study including appropriate pilot studies, development of a validated fMRI paradigm, and specification of quantitative and qualitative data analysis endpoints
  • An overview of the challenges and limitations of performing fMRI evaluation under an Investigational New Drug Application for drug development

"Sponsors are looking for sensitive markers of changes in brain function to determine efficacy of many CNS drugs," stated Dr. Richard Walovitch, President of WCC. "To our knowledge, we are the first imaging service provider to undertake this research challenge. We feel confident that combining the experience of the MGH clinical research team with our unique understanding of imaging paradigms will operationalize this paradigm for use in multi-center clinical trials."

For more information or to register for this free webinar visit: Functional Brain Imaging Using MRI: An Emerging Tool for Drug Development and Clinical Trials.

About WorldCare Clinical

WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 60 countries. WCC's robust technology platform processes over 250 million images annually (CT, MRI, X-Ray, Echo, US, PET). Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.

Media Contact: Thomas O'Donnell, WorldCare Clinical, LLC, 513-924-5183, todonnell@wcclinical.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE WorldCare Clinical

Related Links


Health & Living


Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals

Need Help